444 related articles for article (PubMed ID: 24036474)
1. Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: characterization, stability assessment and cytotoxicity.
How CW; Rasedee A; Manickam S; Rosli R
Colloids Surf B Biointerfaces; 2013 Dec; 112():393-9. PubMed ID: 24036474
[TBL] [Abstract][Full Text] [Related]
2. Development of erythropoietin receptor-targeted drug delivery system against breast cancer using tamoxifen-loaded nanostructured lipid carriers.
Beh CY; How CW; Foo JB; Foong JN; Selvarajah GT; Rasedee A
Drug Des Devel Ther; 2017; 11():771-782. PubMed ID: 28352153
[TBL] [Abstract][Full Text] [Related]
3. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel.
Liu D; Liu Z; Wang L; Zhang C; Zhang N
Colloids Surf B Biointerfaces; 2011 Jul; 85(2):262-9. PubMed ID: 21435845
[TBL] [Abstract][Full Text] [Related]
4. Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study.
Madane RG; Mahajan HS
Drug Deliv; 2016 May; 23(4):1326-34. PubMed ID: 25367836
[TBL] [Abstract][Full Text] [Related]
5. Long chain lipid based tamoxifen NLC. Part II: pharmacokinetic, biodistribution and in vitro anticancer efficacy studies.
Shete H; Chatterjee S; De A; Patravale V
Int J Pharm; 2013 Sep; 454(1):584-92. PubMed ID: 23535344
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen nanostructured lipid carriers: enhanced in vivo antitumor efficacy with reduced adverse drug effects.
Shete HK; Selkar N; Vanage GR; Patravale VB
Int J Pharm; 2014 Jul; 468(1-2):1-14. PubMed ID: 24704438
[TBL] [Abstract][Full Text] [Related]
7. Single-walled carbon nanotubes mediated targeted tamoxifen delivery system using aspargine-glycine-arginine peptide.
Chen C; Hou L; Zhang H; Zhu L; Zhang H; Zhang C; Shi J; Wang L; Jia X; Zhang Z
J Drug Target; 2013 Nov; 21(9):809-21. PubMed ID: 24024582
[TBL] [Abstract][Full Text] [Related]
8. Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer.
Guney Eskiler G; Cecener G; Dikmen G; Egeli U; Tunca B
Eur J Pharm Sci; 2018 Jul; 120():73-88. PubMed ID: 29719240
[TBL] [Abstract][Full Text] [Related]
9. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization.
Shete H; Patravale V
Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345
[TBL] [Abstract][Full Text] [Related]
10. Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment.
Neupane YR; Srivastava M; Ahmad N; Kumar N; Bhatnagar A; Kohli K
Int J Pharm; 2014 Dec; 477(1-2):601-12. PubMed ID: 25445972
[TBL] [Abstract][Full Text] [Related]
11. Formulation Development of Tamoxifen Loaded Lipid Nanoparticle by Taguchi (L
Poovi G; Damodharan N
Curr Comput Aided Drug Des; 2021; 17(1):144-159. PubMed ID: 32196454
[TBL] [Abstract][Full Text] [Related]
12. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
13. Nanomedicine of anastrozole for breast cancer: Physicochemical evaluation, in vitro cytotoxicity on BT-549 and MCF-7 cell lines and preclinical study on rat model.
Shavi GV; Nayak UY; Maliyakkal N; Deshpande PB; Raghavendra R; Kumar AR; Reddya MS; Udupa N; Shrawan B
Life Sci; 2015 Nov; 141():143-55. PubMed ID: 26423561
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the Therapeutic Efficacy of Tamoxifen Citrate Loaded Span-Based Nano-Vesicles on Human Breast Adenocarcinoma Cells.
Kassem MA; Megahed MA; Abu Elyazid SK; Abd-Allah FI; Abdelghany TM; Al-Abd AM; El-Say KM
AAPS PharmSciTech; 2018 May; 19(4):1529-1543. PubMed ID: 29470829
[TBL] [Abstract][Full Text] [Related]
15. Dual drug delivery of tamoxifen and quercetin: Regulated metabolism for anticancer treatment with nanosponges.
Lockhart JN; Stevens DM; Beezer DB; Kravitz A; Harth E
J Control Release; 2015 Dec; 220(Pt B):751-7. PubMed ID: 26344396
[TBL] [Abstract][Full Text] [Related]
16. Enhanced anti-mammary gland cancer activities of tamoxifen-loaded erythropoietin-coated drug delivery system.
Beh CY; Rasedee A; Selvarajah GT; Yazan LS; Omar AR; Foong JN; How CW; Foo JB
PLoS One; 2019; 14(7):e0219285. PubMed ID: 31291309
[TBL] [Abstract][Full Text] [Related]
17. Tadalafil-loaded nanostructured lipid carriers using permeation enhancers.
Baek JS; Pham CV; Myung CS; Cho CW
Int J Pharm; 2015 Nov; 495(2):701-9. PubMed ID: 26423175
[TBL] [Abstract][Full Text] [Related]
18. Nanostructured lipid carriers constituted from high-density lipoprotein components for delivery of a lipophilic cardiovascular drug.
Zhang WL; Gu X; Bai H; Yang RH; Dong CD; Liu JP
Int J Pharm; 2010 May; 391(1-2):313-21. PubMed ID: 20214958
[TBL] [Abstract][Full Text] [Related]
19. pH-responsive drug delivery of chitosan nanoparticles as Tamoxifen carriers for effective anti-tumor activity in breast cancer cells.
Vivek R; Nipun Babu V; Thangam R; Subramanian KS; Kannan S
Colloids Surf B Biointerfaces; 2013 Nov; 111():117-23. PubMed ID: 23787278
[TBL] [Abstract][Full Text] [Related]
20. Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application.
Pardeike J; Weber S; Haber T; Wagner J; Zarfl HP; Plank H; Zimmer A
Int J Pharm; 2011 Oct; 419(1-2):329-38. PubMed ID: 21839157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
